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Abstract
A simple high-performance liquid chromatographic method, using photodiode array detection
was developed for the determination of propylene glycol in human plasma and in the fluid
retreived after continuous veno-venous hemofiltration. The method entailed alkaline derivati-
zation with benzoyl chloride and ethylene glycol as internal standard. The separation of the
compounds, after extraction with pentane, was carried out on a Pursuit C8 column with UV-
detection at 230 nm. Validation samples were analyzed with an accuracy between 95 and
105%, and intra- and inter-day coefficients of variation of less than 8%. The calibration curve
was linear over a concentration range of 5–100 mg L)1 with a detection limit of 1 mg L)1.
Blood plasma samples of several patients were analysed by using the prescribed method with
propylene glycol concentrations varying from 5 to 98 mg L)1. Compared to previously
described LC methods, this method is ten times more sensitive and thus suitable for use in
pharmacokinetic studies of propylene glycol.
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Introduction
Propylene glycol (1,2-propane-diol) is a
chemical agent used to increase the solu-
bilization of non-polar pharmaceuticals
in aqueous solvents. It is considered safe
for use as a vehicle for IV medications by
the US Food and Drug Administration
(FDA) [1]. Parenteral pharmaceutical
preparations containing propylene glycol
include lorazepam, diazepam, nitroglyc-
erin, trimethoprim/sulfamethoxazole,
etomidate and phenytoin. The percentage
of propylene glycol in these solutions
varies from 35 to 80%. Although it is
generally regarded as safe, potential
safety concerns have been described in
patients receiving these parenteral medi-
cations, especially lorazepam, which has
the highest content of 80 percent of pro-
pylene glycol (PG) [2–4]. Long-term
administration of high intravenous doses
of lorazepam can result in propylene
glycol accumulation with toxic effects.
These effects include hyperosmolar met-
abolic acidosis, hemolysis, renal dys-
function, cardiac arrhythmias, seizures
and central nervous system depression [2–
4].
The commonly used analytical meth-
od to quantify glycols with a detection
limit of several mg L)1 is based on gas
chromatographic separation with ﬂame
ionization (FID) or MS detection [5–7].
However during development and vali-
dation of a gas chromatographic method,
we experienced absorbance of the polar
propylene glycol to glass parts of the
injection system. A different method,
using LC—with tandem MS detection
shows a limit of detection (LOD) of
0.3 mg L)1 in rat plasma [8]. However in
the absence of expensive LC–MS–MS
equipment, a different method had to be
found. The lack of UV absorption and
the high polarity of PG make it almost
impossible to analyse it as such with LC.
Derivatization with benzoyl chloride
solves both problems. A quantitative
method was developed by adapting a
previously described LC analysis for the
conﬁrmation of ethylene glycol poisoning
[9]. The FDA recommended maximal
daily amount of propylene glycol is
25 mg kg)1 day)1 [1], therefore a LOD in
the range of several ppm is required for
pharmacokinetic research purposes. In
this paper, we report a relatively simple,
fast and speciﬁc LC method for the
determination of propylene glycol in hu-
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man plasma by using alkaline derivati-
zation with benzoyl chloride and UV-
diode array detection.
Experimental
Materials
Propylene glycol (2 diﬀerent batches,
both >99.5% pure), ethylene glycol
(>99.5% pure) and benzoyl chloride
(>99% pure) were purchased from
Sigma Aldrich (Zwijndrecht, The Neth-
erlands). All other solvents used were of
high-performance chromatography
grade, purchased from VWR (West
Chester, PA, USA).
Instrumentation
The HPLC system comprised an UV
6000LP photodiode array detector
(Thermo-Electron, Waltham, MA,
USA), a 717Plus autosampler (Waters
Corporation, Milford, MA, USA), a
Dionex P680 solvent delivery pump and a
personal computer with Chromeleon
data-acquisition and integration software
(Dionex, Breda, The Netherlands). A
Varian Pursuit RP-8 column (5 lm,
100 · 3 mm ID), ﬁtted with a disposable
RP 10 · 2 mm guard column (Varian
Inc, Palo Alto, CA, USA), was used for
the chromatographic separation at
ambient temperature. The mobile phase
consisted of a mixture of 55% v/v aceto-
nitrile and 45% v/v deionized water and
was refreshed daily. The analysis was run
at a ﬂow-rate of 0.75 mL min)1 with the
detector operating with a spectral range
from 190 to 800 nm. Integration and
quantitation was performed by using
peak height ratios at the absorption
maximum of 230 nm.
Stock Solutions, Calibrators
and Control Samples
A propylene glycol standard solution of
0.10 mg mL)1 as prepared by diluting a
1.0 mg mL)1 stock standard solution
10 times with deionized water. Propylene
glycol calibrators were prepared in blank
plasma with a concentration of 5, 10, 20,
40, 60 and 100 mg L)1. Deionized water
was added to create equal volumes of
200 lL. Calibrators were also used to
determine intra- and inter-day accuracy
and precision (n = 6) of the method.
Validation samples were prepared by
spiking blank plasma with a second batch
of propylene glycol at 10, 50 and
100 mg L)1.
Sample Preparation
A 100 lL aliquot of plasma was added to
a 1.5 mL microcentrifuge tube (Sarstedt,
Nu¨mbrecht, Germany) and 100 lL de-
ionized water and 10 lL internal stan-
dard solution of 0.3 mg mL)1 ethylene
glycol were added. Samples and calibra-
tors were prepared for derivatization by
adding 250 lL 4 M sodium hydroxide
and 5 lL benzoyl chloride. The mixture
was rotated for 10 min at 40 rpm on a
rotation mixer and allowed to stand for
10 min. Hereafter 400 lL pentane were
added and the mixture was rotated for
20 min on a rotation mixer at 40 rpm and
centrifuged at 10,900 rpm for 5 min. The
supernatant was transferred into a new
microcentrifuge tube (Sarstedt), evapo-
rated to dryness under nitrogen at ambi-
ent temperature, dissolved in 150 lL
mobile phase, and 25 lL were injected
into the column. All contacts with glass
parts were avoided by using polypropyl-
ene tubes and ﬂasks.
Results and Discussion
Method Development
Earlier prescribed LC methods with UV
detection have insuﬃcient LOD’s to
quantify low mg L)1 PG levels. Sensitiv-
ity was increased by optimizing derivati-
zation by varying time duration for
mixing and extraction. Optimal values
were found by derivatization for 10 min,
standing for 10 min, and an extraction
time of 20 min.
Validation
A chromatogram obtained with plasma
spiked with 20 mg L)1 propylene glycol
and internal standard ethylene glycol
after derivatization is shown in Fig. 1.
Retention times for both patients and
standards of propylene glycol and inter-
nal standard (ethylene glycol) after
derivatization are 3.1 and 3.9 min with
intra- and inter-day variations of less
than 1 and 3%, respectively. Spectral
analysis from 190 to 800 nm was used to
conﬁrm peak purity and to indicate the
peak identity. The intra- and inter-assay
accuracy and precision are presented in
Table 1. Possible outliers were tested by
using Dixons Q-test. The standard cali-
bration curve (n = 6), was found to be
linear over the concentration range used
as conﬁrmed by analysis of variance
(ANOVA) [10]. A slope of 2.222 ±
0.0005 with an intercept of 1.0320 ±
0.024, and a correlation coefﬁcient of
0.99994 was obtained. A detection limit
of 1 mg L)1, obtained at a signal-to-noise
ratio of 3:1, is sufﬁcient for pharmaco-
kinetic studies of propylene glycol in
plasma. Selectivity of the method was
tested for lorazepam (test concentration
2 mg L)1) and other solvents such as
ethanol, benzyl alcohol and polyethylene
glycol (PEG). These solvents are
Fig. 1. Chromatogram of a plasma sample with a propylene glycol content of 20 mg L)1 after
derivatization. Peaks 1 = internal standard, 2 = PG, peak 3 = unknown
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frequently used as additives in injection
ﬂuids like lorazepam. No interfering
peaks were found at test concentrations
of 5 g L)1. No interfering peaks we found
in pooled human blank plasma.
Stability was tested for human plasma
samples and spiked standards containing
PG concentrations varying from 10 to
100 mg L)1. No signiﬁcant differences
were found.
The method was also tested and vali-
dated for PG analysis in CVVH ﬂuids.
CVVH ﬂuid is an aqueous substance with
electrolytes and is used in continuous
veno-venous hemoﬁltration (CVVH) as a
replacement therapy in case of acute renal
failure [11, 12]. With reference to the
analysis in human plasma, the validation
of PG analysis in CVVH ﬂuid resulted in
equal or better values for the mentioned
validation parameters. No interfering
peaks were found in both blank CVVH
ﬂuid and human pooled CVVH ﬂuid.
Clinical Relevance
A patient with renal failure received a
continuous lorazepam infusion for 98 h
with a cumulative dose of 39.2 g of pro-
pylene glycol. The concentration versus
time curve of this patient is shown in
Fig. 2.
Conclusions
The prescribed method is shorter, uses
less chemical solvents and more impor-
tant is ten times more sensitive than pre-
viously described LC methods. Several
patients were analysed and blood plasma
concentrations of 5–98 mg L)1 of pro-
pylene glycol were found. The presented
LC method is sensitive, simple and suit-
able to investigate propylene glycol
accumulation in patients at risk and/or
can be used in pharmacokinetic studies.
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Table 1. Intra- and inter-day assay accuracy and precision (n = 6)
Concentration (mg L)1) Intra-day Inter-day
Accuracy (%) Precision
(CV) (%)
Accuracy (%) Precision (CV)
10 98.9 5.0 101.0 4.7
50 94.6 7.8 96.7 7.3
99 104.7 6.9 104.8 6.9
Fig. 2. Concentration versus time curve of patient with renal failure. n marks the concentration in
plasma, m the concentration in CVVH ﬂuid
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